Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : NVID International -- Ignore unavailable to you. Want to Upgrade?

To: Naomi who wrote (3242)	1/8/2001 3:41:51 PM
From: Naomi	Read Replies (1) \| Respond to of 3244

NVID NEWS!!! January 08, 2001 15:31 NVID International Announces Axenohl Municipal Water Tests Results; Ionic Silver Technology Found Safe and Effective Jump to first matched term CLEARWATER, Fla.--(BUSINESS WIRE)--Jan. 8, 2001--NVID International Inc. (Pink Sheets:NVID) announced Monday the final results of a research project focused on the effectiveness of Axenohl in a municipal drinking water system in Costa Rica, featuring NVID's ionic silver-based microbial technology. The 4-month study was conducted in the municipal water system of Grecia, a community of 60,000 people just west of San Jose, Costa Rica. EPA protocols were followed in the study and all testing was performed as described in the Standard Methods for the Examination of Water and Waste Water, 19th Edition, 1995. The objective of the study was to determine the effectiveness of Axenohl as a disinfecting agent in municipal water system applications. Prior to testing, the Grecia water supply was contaminated with coliform bacteria and was not potable. After treatment with 78 parts-per-billion (PPB) of Axenohl concentrate, the fecal coliforms went from greater than 200 CFU/100ml to zero in a period of 10 days. No other disinfectants or chemicals (including chlorine) were used in conjunction with Axenohl during the testing period. All water samples taken downstream had less than 50 PPB Axenohl, which falls within the current EPA and European water treatment guidelines for the presence of silver. Additionally, Axenohl proved to control and reduce the presence and growth of biofilm in the piping distribution network. The community of Grecia intends to continue the usage of Axenohl in its water supply network. The data from this study will be submitted to JAMA (Journal of the American Medical Association) and WHO (World Health Organization) for peer review, and ultimately White Paper publication. The project demonstrates the effectiveness and potential of Axenohl as a replacement for traditional water treatment agents. Under a license agreement from NVID, Innovative Medical Services (Nasdaq:PURE) and Sistecam S.A. teamed together under the direction of Andrew Arata, inventor of record for Axenohl, to implement the costly and time consuming Grecia drinking water project in Costa Rica. "The Grecia test results are one more example that prove NVID's aqueous antimicrobial ionic silver technology can realistically be viewed as a breakthrough disinfectant," stated David J. Larson, president NVID International. "Axenohl can effectively compete with traditional water treatment disinfectants without creating any known disinfection by-products, such as trihalomethanes (THM), which have been proven to be carcinogenic." Axenohl is NVID's non-toxic antibacterial technology that uses the biocidal properties of stabilized ionic silver to kill bacteria, viruses and fungi. Axenohl does not include the use of traditional disinfectants such as quaternary ammonium salts, phenols, glutaraldehyde, chlorine or bromine compounds. The Axenohl formulations have been designed to compete, and/or replace these products while eliminating the associated environmental hazards. Additionally, the technology may prove to be revolutionary in the healthcare market for treatment of disease, including human and animal infections and wounds. The disinfection efficacy of Axenohl has been will documented by independent testing laboratories. Axenohl eliminates the following test organism strains all within one minute and 99.9999% efficacy. Pseudomonas aeruginosa ATCC 15442 Staphylococcus aureus ATCC 6538 Salmonella cholerasuis ATCC 10708 E.Coli ATCC 0157:H7 Listeria monocytogenes ATCC 11543 Enterococcus faecium ATCC 11543 Rhinovirus (common colds) Rotavirus (infectious diarrhea) Vancomycin-resistant-enterococci (VRE) Antibiotic-resistant bacteria Target markets include: hospital and nursing home water systems, point-of-use/point-of-entry; municipal, commercial and residential drinking water, FDA compliant consumer products, pools and spas, cisterns/wells, veterinary, horticulture, agriculture and food processing applications. About NVID International Inc. NVID International Inc., based in Clearwater, manufactures and markets patented and patent-pending proprietary ionization disinfection technologies that substantially reduce or replace traditional disinfectants such as chlorine or bromine. The matters discussed in this news release are forward-looking statements with respect to the future activities of the company. These forward-looking statements by their very nature involve risks and uncertainties and represent the company's expectations as of the date of this release. NVID International Inc. and Aqua Bio Technologies Inc. may be reached at: Corporate Office: 28163 U.S. 19 N. Suite 302 Clearwater, Fla. 33761 Contact: David Larson Phone: 727/669-5005 Fax: 727/669-4701 email: dLarson@aquabiotech.com Sales Office: 5153 Sandy Cove Avenue Sarasota, Fla. 34242 Contact: Michael Redden Phone: 941/312-9100 Fax: 941/312-9300 email: aquabiotech@home.com CONTACT: NVID International Inc., Clearwater David Larson, 727/669-5005 dLarson@aquabiotech.com or Michael Redden, 941/312-9100 aquabiotech@home.com